We are thrilled to announce our upcoming Training School on Prime Editing (PE) applications and analysis, hosted at CIEMAT: Centro de investigaciones energéticas medioambientales y tecnológicas, in Madrid (Spain)
Image credit Shuto et al 2024 (Shuto, Y., Nakagawa, R., Zhu, S. et al. Structural basis for pegRNA-guided reverse transcription by a prime editor. Nature631, 224–231 (2024). https://doi.org/10.1038/s41586-024-07497-8)
WHEN? SEPTEMBER 1-2
Tuesday September 1st
08:30
Welcome
09:00
PRIME EDITING – INTRODUCTION AND OVERVIEW Beatriz Olalla
09:20
PRIME EDITING – HOW DOES IT WORK? Johannes Karl Dohr
10:00
PRACTICAL SESSION: PEmax mRNA Part I: • Introduction: Steps to perform a Prime editing experiment. • Hands on: In vitro transcription of PEmax mRNA.
12:00
GUIDE DESIGN TOOLS Sofia Ottonello
12:45
LUNCH BREAK
14:00
PRACTICAL SESSION: PEmax mRNA Part II: • Hands on: DNAse treatment • Hands on: Poly(A) tail addition
15:00
PRACTICAL SESSION: PegRNA and sgRNA design Sofia Ottonello
16:00
PRACTICAL SESSION: PEmax mRNA Part III: • Hands on: mRNA purification • Hands on: mRNA quantification • Hands on: mRNA quality Control – Qubit quantification
18:00
Questions & Answers
20:00
Networking event
Wednesday September 2nd
09:00
PRIME EDITING APPLICATIONS: • Epidermolysis Bullosa – Alex Bassons • Fanconi anemia – Beatriz Olalla • Cardiomyopathies – Johannes Karl Dohr & Sofia Ottonello
11:00
PRACTICAL SESSION: PE system nucleofection: – Introduction: Experimental workflow: From electroporation to PCR analysis • Hands on: Nucleofection in suspension cells • Hands on: Nucleofection in adherent cells
14:00
LUNCH BREAK
15:30
PRIME EDITING SAFETY: OFF-TARGET ACTIVITY Sergio López
16:00
PRACTICAL SESSION: • Introduction: Next steps and data analysis • Hands on: CRISPResso analysis
17:30
Questions & Answers Adjourn
Application & Funding
GenE-HumDi courses are open to all EU members and Near Neighbour Countries, with a particular focus on promoting the participation of Inclusiveness Target Countries and encouraging Early career scientist.
Cost: Selected attendees are enrolled free of charge.
Limited Capacity: Seats are strictly limited to ensure high levels of interaction between trainers and trainees.
Funding: A call is now open to provide financial support for travel costs and daily allowances for selected participants, in accordance with COST guidelines.
We are thrilled to announce our upcoming Training School on Homology-Directed Repair (HDR) and Adeno-Associated Virus (AAV) Based Delivery Technologies, hosted at the Kavli Institute for Systems Neuroscience in Trondheim, Norway.
June 24th -26th, write it down now!!
This 3-day intensive course is designed for researchers and professionals looking to master precise DNA repair mechanisms and cutting-edge gene delivery platforms. Participants will explore the theoretical foundations of genomic integrity and gain practical insights into leveraging these pathways for accurate gene editing applications, specially addressed towards therapeutic use.
The training is structured into three thematic days, each led by distinguished experts in the field:
June 24th:
T Cells In Vitro Gene Editing & HDR Strategies
Focus: Molecular mechanisms of HDR, designing HDR experiments for CAR-T cell therapies, and drug modulation to enhance repair efficiency.
Hematopoietic Stem Cells (HSCs), In Vivo Gene Editing & Metabolic Diseases
Focus: HSC biology, HDR strategies for in vivo editing, and clinical approaches for treating metabolic diseases through genomic modification.
Confirmed Speakers & Organizers: Gloria Gonzalez-Aseguinolaza and Jose-Carlos Segovia
June 26th:
AAV-Based Delivery of Gene-Editing Components
Focus: AAV production strategies (iodixanol gradient vs. affinity chromatography), cell-type specific delivery, and qPCR-based vector titration.
Confirmed Speakers & Organizers: Rajeevkumar Raveendran Nair, Dr. Sofie Snipstad, and Petter Anderse
Training overview
This course offers an in-depth overview of Homology-Directed Repair (HDR) and homologous recombination, two fundamental cellular mechanisms for precise DNA repair and genome engineering. The training will take place June 24th to June 26th, and is designed for researchers, students, and professionals interested in understanding how these pathways maintain genomic integrity and how they can be leveraged for accurate gene editing applications. The program will cover the molecular mechanisms underlying HDR and homologous recombination, with a particular focus on their use in CRISPR/Cas-based genome editing strategies. Participants will explore real-world case studies and experimental approaches aimed at achieving precise genetic modifications through HDR. The training school will focus as well on adeno-associated virus (AAV) delivery vectors and their applications in gene editing, together with an overview of current production platforms for research. Key purification approaches, including iodixanol gradient ultracentrifugation and affinity chromatography, will be discussed, with emphasis on the critical steps involved in these techniques. The program will also cover vector titration using quantitative PCR (qPCR) and the interpretation of resulting data.
In addition, the course will address current challenges and limitations associated with HDR-based editing, including efficiency and cell-cycle dependence, as well as emerging strategies to enhance HDR outcomes. Alternative DNA repair pathways, such as Non-Homologous End Joining (NHEJ) and base editing technologies, will also be discussed to provide a comprehensive perspective on genome editing approaches. By the end of the course, participants will have gained both theoretical insights and practical guidance to apply, HDR, homologous recombination, and AAV production techniques, effectively in their own research projects.
Main Objectives
To provide a comprehensive understanding of the molecular mechanisms underlying Homology-Directed Repair (HDR) and homologous recombination.
To explain the role of HDR and homologous recombination in maintaining genomic integrity and enabling precise genome editing.
To explore how HDR pathways can be harnessed for accurate genetic modifications using CRISPR/Cas-based technologies.
To analyze the limitations and challenges associated with HDR-mediated genome editing and discuss strategies to enhance editing efficiency.
To compare HDR with alternative DNA repair and genome editing pathways, including Non-Homologous End Joining (NHEJ) and base editing.
To equip participants with practical knowledge and experimental design skills to apply HDR-based genome editing approaches in their own research projects.
To understand Adeno-associated virus (AAV) delivery vectors and their applications in gene editing.
To discuss critical steps involved in iodixanol-based purification compared to chromatography-based methods.
To demonstrate vector titration using quantitative PCR (qPCR) and interpretation of resulting data.
Expected Outputs
● Participants will gain a solid theoretical understanding of Homology-Directed Repair (HDR) and homologous recombination mechanisms.
● Participants will be able to design and plan genome editing experiments that utilize HDR pathways for precise genetic modifications.
● Participants will acquire practical experience in laboratory techniques for HDR-based genome editing and in the bioinformatics analysis of the recombination outcome
● Participants will be able to critically evaluate the limitations and efficiency of HDR in different experimental contexts and propose strategies to overcome them.
● Participants will understand and compare alternative DNA repair and genome editing pathways, including NHEJ and base editing, and their applications.
● Participants will be equipped to apply HDR and homologous recombination knowledge to their own research projects, enhancing experimental design and outcome predictability.
● Participants will acquire knowledge on adeno-associated virus (AAV) delivery vectors and their applications in gene editing, alongside an overview of current research production platforms.
● Participants will understand the key purification approaches, including iodixanol gradient ultracentrifugation and affinity chromatography, as well as vector titration by qPCR, with emphasis on critical methodological steps
Application & Funding
GenE-HumDi courses are open to all EU members and Near Neighbour Countries, with a particular focus on promoting the participation of Inclusiveness Target Countries and encouraging Early career scientist.
Cost: Selected attendees are enrolled free of charge.
Limited Capacity: Seats are strictly limited to ensure high levels of interaction between trainers and trainees.
Funding: A call is now open to provide financial support for travel costs and daily allowances for selected participants, in accordance with COST guidelines.
We support early career and young researchers in the field of therapeutic Gene Editing. For this reason, we are very excited to announce that we will be supporting selected young members attending the CRISPRMED26 Conference and enrolled in the CRISPRMED26 Workshops, co-organized by GenE-HumDi (COST action CA21113) and CRISPR MEDICINE NEWS (CRISPRMED) as part of the CRISPRMED’26 conference. The CRISPRMED26 workshops offer students an interactive opportunity to acquire critical applied knowledge and skills that will expand their profile in the gene-editing field. With a limited number of 30 places per workshop, we focus on delivering high-quality, interactive workshops in which you can learn by doing instead of just listening.
📚 Workshop Topics And FacilitATors
Tools: Choosing the Right Gene-Editing Approach Dr. Claudio Mussolino, (Universitaetsklinikum Freiburg. Germany) Dr. Raúl Perez-Jimenez, (Ikerbasque Research Professor. Spain) Dr. Antonio Carusillo, (Università di Modena e Reggio Emilia. Italy)
The workshop will start with an introduction to various genome-editing technologies highlighting their mechanisms, advantages, and limitations.
We will also discuss recent developments in genome-editing tools, focusing on those DSB-free and with demonstrated therapeutic potential, such as base- and prime editing. Next, we will cover criteria for selecting the appropriate genome-editing tool based on the targeted disease and present case studies of therapeutic applications.
We will emphasise that different diseases require distinct genome-editing strategies depending on the aim, such as gene replacement, gene restoration, or gene insertion.
The workshop will include a hands-on session with practical demonstrations and group activities to design genome-editing experiments. Finally, we will address ethical and safety considerations, emphasising regulatory guidelines and best practices.
The workshop will be highly interactive, with Q&A sessions throughout, pausing at key points for discussion.
Delivery: Navigating the CRISPR Delivery Landscape Dr. Juan Antonio Marchal, (University of Granada.Spain) Dr. André Görgens, (Karolinska Institutet | Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine. Sweden)
This workshop will focus on navigating the current landscape of viral- and non-viral delivery methods for CRISPR gene-editing tools.
The session will provide the participants a broad and comparative introduction on the various delivery methods available for the different CRSPR gene-editing tools, their advantages and disadvantages.
Importantly, the workshop will try to achieve a comprehensive understanding on how to select the right delivery tool for a specific CRISPR gene editing in cells to achieve high efficacy, the so-called “CRISPR-Delivery-Cell, CDC” match-making procedure.
Safety: Pre-clinical Safety Analyses Dr. Ciaran Lee PhD (University College Cork. Ireland)
This workshop will focus on the side effects derived from the use of genome editors. The session will address the risks associated with the unspecific activity of CRISPR-based platforms, which can impact both the safety and efficacy of gene-editing approaches. Participants will gain a comprehensive understanding of the different types of potential genotoxic events and of the different methods available to monitor unintended genomic modifications, including those aligned with regulatory guidelines:
– Off-target activity of genome editors
– Genotoxicity: on- and off-target aberrations
– Off-target evaluation methods
– Mitigation strategies
– Hands-on basic training on specificity prediction
📝 SuCCESS
Close to a hundred young researchers and experts participated of these workshops to update and bring cutting edge genome editing. Researchers highlighted the possibilities and capabilities of state of the art technologies and also put their performance on the spotlight to realize the need for detailed selection on genome editing tools and delivery strategies and current limitations predicting safety based solely on bio models.
Picture Credits : Karim Bebadellah .Copenhagen, April 14th 2026
Picture Credits : Karim Bebadellah .Copenhagen, April 14th 2026
The GenE-HumDi COST Action organized the CRISPRMED26 Satellite Meeting“Access, IP Landscape and FTO“ in Copenhagen.
The coordinated panel sessions on Access, IP Landscape, and FTO, which culminated in a high-level Panel Discussion participated by GenE-HumDi experts Meliha Negin and Leonardo Martin. This has been a unique opportunity to engage with the world’s leading experts in gene editing law, patenting, and clinical regulation
🗺️ Access, IP Landscape and FTO
In Copenhagen, during the CRISPRMED26 Satellite Sessions on April 13th, we are deep diving into the legal hurdles of gene editing with global experts including Ulrich Storz, Franziska Bächler, Jacob S. Sherkow, Timo Minssen, and Kevin E. Noonan
The GenE-HumDi Panel: The afternoon concludes with a cross-disciplinary panel discussion featuring Meliha Negin and Leonardo Martin, bridging the gap between scientific innovation, patent protection, and regulatory approval.
📚Panel Discussion
The discussion panel was participated by experts and members interested in Gene Editing Patent(s) and IP. After the Satellite Session a working panel discussed freedom to operate in the genome editing field and protection of intellectual property¡, which is key to gain interest of mayor market stakeholders to become involved and secure commercial distribution of Medical advances.
Event Pictures
Photograph credits: Raquel Soriano, Copenhagen, April 13th, 2026 (Updated April 15th)
Call for Action Ambassadors: Represent GenE-Humdi on the Global Stage.
Deadline Extended!
The GenE-Humdi COST Action (CA21113) is looking for dedicated members to serve as the voice of our network at major international scientific forums This Conference Grant is specifically designed for researchers who will present our collective milestones, activities, and results.
The Mission: Visibility & Impact The primary goal of this grant is the strategic promotion of the GenE-Humdi Action. We are seeking presenters who can:
Increase the visibility of CA21113 within the research community.
Disseminate GenE-Humdi results to high-profile end-users and regulatory stakeholders.
Attract new participants and stakeholders to our network.
What We Support We provide up to 2,500 € for in-person attendance at conferences where the grantee will deliver an oral presentation featuring the GenE-Humdi COST Action. * (Actual fund is decided based on the information provided in the application). Selection is heavily weighted toward how well the presentation aligns with the Action’s strategic priorities and its contribution to our collective dissemination goals.
How to Apply Applicants must demonstrate a clear commitment to increasing the visibility of CA21113.
Deadline: April 6th.
Process: Submit via the e-COST management tool.
Requirements: Include an acceptance letter and a commitment letter justifying how your participation promotes the Action.
🌟 Call for attendees to the CRISPRMED26 Satellite Meetings! 🌟
Dear GenE-HumDi Members,
The GenE-HumDi COST Action is pleased to announce a call for Travel Grants to support the participation of young researchers and industry professionals in the upcoming CRISPRMED26 Satellite Meeting“Access, IP Landscape and FTO“ in Copenhagen.
This call specifically targets those attending the coordinated panel sessions on Access, IP Landscape, and FTO, which will culminate in a high-level Panel Discussion participated by GenE-HumDi experts Meliha Negin and Leonardo Martin. This is a unique opportunity to engage with the world’s leading experts in gene editing law, patenting, and clinical regulation
🗺️ Access, IP Landscape and FTO
In Copenhagen, during the CRISPRMED26 Satellite Sessions on April 13th, we are deep diving into the legal hurdles of gene editing with global experts including Ulrich Storz, Franziska Bächler, Jacob S. Sherkow, Timo Minssen, and Kevin E. Noonan
The GenE-HumDi Panel: The afternoon concludes with a cross-disciplinary panel discussion featuring Meliha Negin and Leonardo Martin, bridging the gap between scientific innovation, patent protection, and regulatory approval.
📚 Who can apply?
We are considering:
Young Researchers: PhD students, Post-docs, Junior PI (40 years old or younger).
Industry Members: Professionals from SMEs or the pharmaceutical sector related to Gene Editing Therapies (40 years old or younger).
Applicants must be affiliated to GenE-HumDi COST Action to be able to submit the applications ( need access through : https://e-services.cost.eu/). Funding is open to all COST Action members, but active members a within the network are encouraged to apply.
💶What does the grant cover?
Long-distance travel support to/from the venue*
Daily allowance for the day of the Satellite meeting plus the corresponding part of the days required for travel*
*Long-distance travel expenses and daily allowance will be reimbursed according to the approved budget and will abide by current COST annotated rules.
📝 How to Apply:
Interested attendees must apply soon:
Send an email to the Grant Holder Manager (raquel.soriano@juntadeandalucia.es) Please, kindly provide information about the state of your application for the Satellite Meetings.
Include in the email a letter of interest, of about 1,000 words addressed to the Grant Awarding Coordinator. Please include:
A contact e-mail address (if different from your COST contact).
Your current position.
Whether you are an active member in any GeneHumdi WG.
List your contributions to GeneHumdi initiatives (meetings, white papers, peer-reviewed papers, etc, …)
How attending will benefit their current position or future perspectives?
How does your work/research/interest align with the satellite topic ” Access, IP Landscape and FTO“. PLease, mention your:
Gene Editing Patent(s) developed: Provide the Patent Title(s) and descriptive keywords (ensure no confidential or unpublished information is disclosed)
Patent Status: (e.g., Filed, Pending, or Granted).
IP Experience: A brief summary of your previous experience with Intellectual Property or the patenting process.
📅 Deadline:
Applications will be considered from January 19th and
no later thanFebruary 28th!
This date is needed to allow the timely resolution and communication of grants on time for the participants to arrange their itineraries to/from the venue.
The budget is limited and active young members not previously selected for funded participation in GeneHumdi calls will be given priority. COST YRIs having and oral communication already accepted by the CRISPR MEDICINE 26 conference will be positively considered during the application evaluation.
The Grant Award Coordinator will ensure fair review of all applications and shortlisted applicants are expected to receive feedback by the second week of March.
📚 Call Documentation:
Don’t miss this opportunity to enhance your knowledge and network with experts in the field!
For questions or to submit your application, contact the Grant Holder Manager at raquel.soriano@juntadeandalucia.es.
On February 11, we celebrate the Women and girls in Science and Technology, #Women in science.
For the past 3 years we feature successful female leaders from our COST Action CA21113. As they are inspiration for younger scientist.
This year we feature on of our youngest @genehumdi members : María Ortiz who is developing advanced genome editing tools for immunotherapy in Granada. She borrow a fierce quote from Nobel Laureate Barbara McClintock:
GenE-HumDi encourages and support girls and young female researchers to pursue the dream of Using Genome Editing for the treatment of Huma Diseases by offering support and a network of peers to boost their research through collaborative training and research.
Previous Inspirational quotes:
#WomenInScience 2025 inspirational quote was favourite of Dr. Carla Fuster. Leader expert in Genome Editing off-target evaluation and genotoxicity. Her inspirational choice, coined by professor Lynn Margulis, can´t get any better alignment with our COST Action principles.
#WomenInScience 2024 featured a inspirational quote from Nobel Laureate Rita Levi Montalcini, favourite of Annarita Miccio a world class Scientist Researching genome Editing to boost therapeutic approaches for hematologic genetic disorders.
#WomenInScience 2023 opened with a quote hand picked by our COST action Chair Alexia Cavazza. She was inspired by pioneer Afro American Astronaut Mae Jemison encouraging curiosity, which is universally accepted to be the fuel of good research.
This post seek to Acknowledge all women in GeneHumdi COST Action. As they stand as true references and inspiration for young scientist and because, this COST Action would not be possible without their talent and commitment.
🌟 Call for attendees to the CRISPRMED26 Workshops! 🌟
Dear GenE-HumDi Members,
We support early career and young researchers in the field of therapeutic Gene Editing. For this reason, we are very excited to announce that we will be supporting selected young members attending the CRISPRMED26 Conference and enrolled in the CRISPRMED26 Workshops, co-organized by GenE-HumDi (COST action CA21113) and CRISPR MEDICINE NEWS (CRISPRMED) as part of the CRISPRMED’26 conference. The CRISPRMED26 workshops offer students an interactive opportunity to acquire critical applied knowledge and skills that will expand their profile in the gene-editing field. With a limited number of 30 places per workshop, we focus on delivering high-quality, interactive workshops in which you can learn by doing instead of just listening.
🗺️ When and where?
The CRISPRMED26 workshops will be held from 9:00-13:30 CEST on the 14th April 2026.
Each workshop will last 1 hour and 25 minutes.
📚 Workshop Topics And FacilitATors
Tools: Choosing the Right Gene-Editing Approach Dr. Claudio Mussolino, (Universitaetsklinikum Freiburg. Germany) Dr. Raúl Perez-Jimenez, (Ikerbasque Research Professor. Spain) Dr. Antonio Carusillo, (Università di Modena e Reggio Emilia. Italy)
The workshop will start with an introduction to various genome-editing technologies highlighting their mechanisms, advantages, and limitations.
We will also discuss recent developments in genome-editing tools, focusing on those DSB-free and with demonstrated therapeutic potential, such as base- and prime editing. Next, we will cover criteria for selecting the appropriate genome-editing tool based on the targeted disease and present case studies of therapeutic applications.
We will emphasise that different diseases require distinct genome-editing strategies depending on the aim, such as gene replacement, gene restoration, or gene insertion.
The workshop will include a hands-on session with practical demonstrations and group activities to design genome-editing experiments. Finally, we will address ethical and safety considerations, emphasising regulatory guidelines and best practices.
The workshop will be highly interactive, with Q&A sessions throughout, pausing at key points for discussion.
Delivery: Navigating the CRISPR Delivery Landscape Dr. Juan Antonio Marchal, (University of Granada.Spain) Dr. André Görgens, (Karolinska Institutet | Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine. Sweden)
This workshop will focus on navigating the current landscape of viral- and non-viral delivery methods for CRISPR gene-editing tools.
The session will provide the participants a broad and comparative introduction on the various delivery methods available for the different CRSPR gene-editing tools, their advantages and disadvantages.
Importantly, the workshop will try to achieve a comprehensive understanding on how to select the right delivery tool for a specific CRISPR gene editing in cells to achieve high efficacy, the so-called “CRISPR-Delivery-Cell, CDC” match-making procedure.
Safety: Pre-clinical Safety Analyses Dr. Ciaran Lee PhD (University College Cork. Ireland)
This workshop will focus on the side effects derived from the use of genome editors. The session will address the risks associated with the unspecific activity of CRISPR-based platforms, which can impact both the safety and efficacy of gene-editing approaches. Participants will gain a comprehensive understanding of the different types of potential genotoxic events and of the different methods available to monitor unintended genomic modifications, including those aligned with regulatory guidelines:
– Off-target activity of genome editors
– Genotoxicity: on- and off-target aberrations
– Off-target evaluation methods
– Mitigation strategies
– Hands-on basic training on specificity prediction
💶 Gene-HumdI TRAVEL GRANTS COVER:
Long-distance travel support to/from the venue*
Daily allowance for the workshop*
*Long-distance travel expenses and daily allowance will be reimbursed according to the approved budget and will abide by current COST annotated rules.
📝 How to Apply:
Interested attendees must apply soon:
Send an email to the Grant Holder Manager (raquel.soriano@juntadeandalucia.es) indicating the state of your application for the workshop, application abstract ( if submited) and providing your chosen topic.
Include in the email a letter of interest, of no more than 1,000 words addressed to the Grant Award Coordinator. Please include:
A contact e-mail address if different from your COST contact.
Your current position
Whether you are an active member in any GeneHumdi WG.
List your contributions to GeneHumdi initiatives (meetings, white papers, peer-reviewed papers, etc, …)
How does your work/research/interest align with the workshop topics?
How attending will benefit their current position or future perspectives?
📅 Deadline:
Applications will be considered from January 28th and
no later thanFebruary 20th!
This date is needed to allow the timely resolution and communication of grants.
The budget is limited and active young members not previously selected for funded participation in GeneHumdi calls will be given priority. Like, oral communication already accepted by the CRISPR MEDICINE 26 conference will be positively considered during the application evaluation.
The Grant Award Coordinator will ensure fair review of all applications and shortlisted applicants are expected to receive feedback by the second week of March.
The 4th Annual Meeting of our network, “Genome Editing for the treatment of Human Disease” COST Action CA21113, will be held next May 26-28 in Granada ( Spain).
Joining Forces for the Future of Gene Editing: See You in Granada for the GenE-HumDi Annual Meeting!
We are delighted to announce that the countdown has begun for the GenE-HumDi Annual Meeting 2026, which will take place in the beautiful city of Granada, Spain, from May 26th to 28th. Hosted at the prestigious GENYO center (Centre for Genomics and Oncological Research), this gathering represents a cornerstone for our network as we continue our mission to bridge the gap between benchside research and clinical application in the field of genome editing.
A Hub for Innovation and Translation
As part of the COST Action CA21113, GenE-HumDi is dedicated to accelerating the translation of genome-editing (GE) technologies into life-changing treatments for human diseases. This year’s program is packed with insightful sessions designed to foster collaboration across academia, industry, and regulatory bodies.
Highlights of the Scientific Programme include:
Cutting-Edge Technologies: Sessions on genome engineering developments and novel delivery systems, featuring experts like Marcello Maresca and Axel Schambach.
Safety and Regulation: In-depth discussions on safety profiling, off-target detection, and the evolving EU regulatory landscape for genome editing.
Clinical Horizons: Presentations on clinical applications for diseases ranging from Duchenne muscular dystrophy to inherited anemias.
Keynote Lecture: We are honored to welcome Zoltan Ivics, who will share his expertise on non-viral genetic engineering using transposon technologies.
Preliminar Agenda !
Empowering the Next Generation
A vital part of our network is supporting our Early Career Investigators. We look forward to the “Training & Mobility” session, where our STSM (Short Term Scientific Mission) fellows will present their collaborative work and progress. These young researchers are the future of genomic medicine, and their fresh perspectives are central to our success.
Networking and Culture in Granada
Beyond the laboratory and lecture hall, the meeting offers unique opportunities to build lasting professional bonds in a relaxed and amicable atmosphere:
Welcome Reception: Sponsored by the Spanish Society of Gene and Cell Therapy (SETGyC), providing a warm start to our three-day journey.
Scientific Exchange at the Alhambra: A private visit to one of the world’s most stunning architectural wonders, perfect for informal discussions.
Gala Dinner: We will conclude our meeting with a traditional Andalusian dinner at Carmen de la Victoria, overlooking the breathtaking views of the Alhambra.
We would like to express our gratitude to our host, the Fundación Progreso y Salud, and our supporters, including SETGyC, IDT (Integrated DNA Technologies), and Miltenyi Biotec, whose contributions make this vibrant exchange of ideas possible.
We look forward to welcoming old friends and new collaborators to Granada for three days of science, inspiration, and community.
🌟 Calling All Young Innovators: Present Your Genome Editing Research Internationally!
GenE-HumDi nurtures visibility of Young Scientist and Innovators by supporting their presence in international forums.
Are you a young researcher or innovator under the age of 40? Do you have exciting findings in genome editing that you want to share with the global scientific community? GenE-HumDi is here to help you get there!
We are thrilled to announce the open call for the 2026 Young Researcher and Innovator (YRI) Conference Grants. These grants are specifically designed to empower the next generation of scientists by providing financial support to attend and present at high-level international conferences.
What’s in it for you?
Successful applicants can receive up to €2,000 in funding*. This grant acts as a contribution toward your:
Travel expenses.
Accommodation and meals (subsistence).
Conference registration fees.
Poster printing and other relevant costs.
*Proposals could be shortlisted based on evaluation scores to match funding constrains.
Is your research a match?
While we welcome all work related to genome editing, we are particularly interested in projects focusing on:
The GeneHumdi Grant Awarding committee will assess each proposal Application Period: This is an open call—you can apply at any time before August!
Conference Dates: Your chosen conference must take place between January 2026 and July 2026.
How to Apply
To be eligible, you must be under 40 and affiliated with a legal entity in a COST Member Country, NNC, or European RTD Organization. Applications should be submitted through the e-COST portal, ensuring your work aligns with the scientific goals of the Action.
Don’t miss this chance to boost your visibility and network with experts in your field!
COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks. Our Actions help connect research initiatives across Europe and beyond and enable researchers and innovators to grow their ideas in any science and technology field by sharing them with their peers. COST Actions are bottom-up networks with a duration of four years that boost research, innovation and careers.
